Old Web
English
Sign In
Acemap
>
Paper
>
1620O Phase I study of TK216, a novel anti-ETS agent for Ewing sarcoma
1620O Phase I study of TK216, a novel anti-ETS agent for Ewing sarcoma
2020
Joseph A. Ludwig
Noah Federman
Pete Anderson
M. E. Macy
L.E. Davis
R.F. Riedel
J.A. Muscal
N. C. Daw
Ravin Ratan
J Toretsky
X. Ianopulos
F. J. Hsu
J. B. Breitmeyer
Paul A. Meyers
Keywords:
Cancer research
phase i study
Sarcoma
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
3
Citations
NaN
KQI
[]